Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pediatric

Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2022 - 2028

The clinical nutrition market is speculated to grow considerably by 2028 on account of surging consumption of junk food leading to malnutrition among children and adults around the world. In addition, the expanding geriatric population base worldwide is likely to propel industry adoption over the forecast period.

Growing understanding of metabolic abnormalities and nutritional assessment in acute and chronic disorders has encouraged significant breakthroughs in nutritional support research, design, and clinical application, which has augmented market uptake over the past few years.

The clinical nutrition market has been segregated based on distribution channel, product, application, consumer, and region. From the product point of view, the market has further been bifurcated into parenteral nutrition, infant nutrition, and enteral nutrition.

In 2021, the infant nutrition sub-segment held a valuation of around USD 26,227 million and is estimated to develop at a CAGR of almost 9.0% over the review period. This growth is attributed to the prevailing malnourishment in children and premature birth.

With respect to consumer, the clinical nutrition market has been categorized into adult and pediatric. The pediatric sub-segment was worth over USD 28,215 million in 2021 and is anticipated to grow at approximately 9.1% CAGR through the study timeframe. Increasing incidences of chronic diseases in infants leading to malnutrition among the pediatric population base is likely to fuel segmental expansion over 2022-2028.

From the application perspective, the market has been classified into gastrointestinal disorders, cancer, neurological disorders, metabolic disorders, and others. In 2021, the clinical nutrition market from the gastrointestinal disorders sub-segment surpassed a valuation of USD 12,487 million and is speculated to progress at above 9.1% CAGR between 2022 and 2028. Rising prevalence of GI disorders in pediatric and geriatric patients due to lack of proper nutritional intake via diet to maintain a healthy body is likely to bolster industry uptake over the next few years.

In terms of distribution channel, the clinical nutrition industry has been segmented into online channels, retail stores, pharmacies & drug stores, and others. The online channels sub-segment was valued at more than USD 7,883 million in 2021 and is expected to expand at a CAGR of about 9.6% through the assessment period. This expansion is attributed to the ease and convenience of using an online portal, especially amidst the prevailing threat of the COVID-19 pandemic.

On the regional front, the North America clinical nutrition market exceeded a valuation of USD 12,913 million in 2021 and is set to grow at around 8.3% CAGR over the forecast period. Recent advancements in nutritional formulas and supportive government initiatives to promote clinical nutrition products are likely to drive regional market development in the coming time period.